Transaction · 0000886982-26-000522
ATTOAttovia Therapeutics, Inc.
Goldman Sachs Group Inc
GOLDMAN SACHS GROUP INC, 10%, reported an open-market or private sale at Attovia Therapeutics, Inc. involving 447.000000 shares for an estimated $9775.89. Reported holdings after the transaction were 83565.000000 shares. A 10b5-1 reference was not detected in the stored filing text.
Open-market sellSEC transaction code S10%
- Trade date
- Aug 05, 2026
- Filing date
- Aug 28, 2026
How reported position traded is calculated
Shares sold ÷ (holdings after + shares sold). Estimated position before: 84,012 shares.
Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.
Filing warnings
Notes recorded with this filingamended filingThis transaction comes from an amended Form 4 filing.
delayed filingThe filing was reported 23 calendar days after the transaction date.
ATTO price since this filing
Daily closing prices, with the filing date and available return windowsATTO · Daily closing priceLoading daily prices…
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago1w ago1d ago
Returns since7d30d90d180d1y
Transaction facts
Stored Form 4 columns with their raw values
- Type
- Sell Code S
- Identifier
- 0000886982-26-000522 Common Stock
- Transaction date
- Aug 05, 2026 Filed Aug 28, 2026, 09:38 PM · 23d delay
- Shares
- 447 sh $21.87 per share
- Estimated value
- -$9.77k Computed from shares × price
- Holdings after
- 83,565 sh Indirect · See Footnotes
Filing signal explanations
Badges describe filing facts only — not predictions.
Cluster 14dRepeat 30dPattern $100kLarge $1.00M
Amended Filing Delayed Filing
Filing-only score
-12 points
Compact filing score computed from stored Form 4 facts. Version v1.
Mixed or weak signal
This filing has a negative filing-only score. It may be less informative as an insider-activity signal and needs extra context.
How this score is calculated
- amended_filing-6 points
is_amendment = true
Amended filing: the original transaction may have been restated. - delayed_filing-6 points
reporting_delay_days = 23
Filing delay exceeds the configured threshold.
Signed filing-only points, not a probability or expected return. Version v1.
Reported relationships & other filings
Form 4 relationship flags and nearby filing context
Reported roles
No officer title
Officer NoDirector No10% NoOther Yes
Footnotes & amended
- F1
Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an ad…
- F2
These transactions in or with respect to the common stock of the Issuer were effected by Goldman Sachs & Co. LLC ("GS&Co") acting as a market maker in the ordinary course of business. Without concedin…
- F3
GS&Co's transactions in or with respect to the Issuer's common stock on August 5, 2026 consisted of purchases of a total of 85,000 shares, sales of a total of 105,807 shares, and establishment of long…
- F4
The previous report on Form 3 reflected an administrative error with respect to the number of shares of common stock issuable upon conversion of the Preferred Stock, which is corrected in this Form 4.…
- F5
All shares of the Issuer's redeemable convertible preferred stock automatically converted into shares of the Issuer's common stock on a 1-for-1 basis, adjusted for a 1-for-9.29 reverse stock split eff…
- F6
This statement is being filed by Goldman Sachs Group, Inc. ("GS Group"), GS&Co, Goldman Sachs Asset Management, L.P. ("GSAM LP"), Broad Street Principal Investments L.L.C. ("BSPI"), which directly hol…
- F7
(continued from footnote 6)...WSLS Emp Offshore Investments, L.P. ("WSLS Emp Offshore"), which directly holds 36,927 shares of common stock purchased in the IPO and 179,879 shares of common stock conv…
Related transactions
Same SEC filing0 other transactions
Recent company activity
ATTO0 recent txs